Gsk Plc-spon Adr. Earnings

Gsk Plc-spon Adr.’s revenue jumped 1.29% since last year same period to $7986Mn in the Q2 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 6.25% jump in its revenue since last 3-months.

Gsk Plc-spon Adr.’s net profit jumped 23.02% since last year same period to $1443Mn in the Q2 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated -11.15% fall in its net profits since last 3-months.

Gsk Plc-spon Adr.’s net profit margin jumped 21.45% since last year same period to 18.07% in the Q2 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated -16.37% fall in its net profit margins since last 3-months.

Gsk Plc-spon Adr.’s price-to-earnings ratio after this Q2 2025 earnings stands at 17.69.

Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current quarter stand at 1.24 - a 7.83% jump from last quarter’s estimates.

Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current year stand at 1.24.

Gsk Plc-spon Adr.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Gsk Plc-spon Adr. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.